Strs Ohio lessened its stake in shares of Cigna Corp (NYSE:CI) by 5.2% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 173,696 shares of the health services provider’s stock after selling 9,596 shares during the quarter. Strs Ohio’s holdings in Cigna were worth $27,365,000 at the end of the most recent reporting period.
Several other hedge funds also recently added to or reduced their stakes in the company. Truvestments Capital LLC bought a new position in Cigna in the 1st quarter valued at about $37,000. C J Advisory Inc bought a new position in Cigna in the 1st quarter valued at about $40,000. Lavaca Capital LLC bought a new position in Cigna in the 1st quarter valued at about $40,000. Trustcore Financial Services LLC bought a new position in Cigna in the 1st quarter valued at about $49,000. Finally, Baldwin Brothers Inc. MA bought a new position in Cigna in the 1st quarter valued at about $50,000. 88.13% of the stock is currently owned by institutional investors.
NYSE:CI traded up $1.44 on Wednesday, hitting $165.16. The stock had a trading volume of 609,272 shares, compared to its average volume of 2,240,500. The firm’s fifty day simple moving average is $166.48. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.84. Cigna Corp has a 1 year low of $141.95 and a 1 year high of $226.60. The firm has a market cap of $62.67 billion, a PE ratio of 11.61, a P/E/G ratio of 0.84 and a beta of 0.70.
Several equities analysts recently weighed in on CI shares. Zacks Investment Research cut shares of Cigna from a “buy” rating to a “hold” rating and set a $164.00 price target on the stock. in a research report on Tuesday, June 11th. ValuEngine lowered shares of Cigna from a “hold” rating to a “sell” rating in a research note on Tuesday, July 23rd. Citigroup decreased their price objective on shares of Cigna from $228.00 to $203.00 and set a “buy” rating for the company in a research note on Monday, June 3rd. Raymond James increased their price objective on shares of Cigna from $185.00 to $190.00 and gave the company an “outperform” rating in a research note on Friday, August 2nd. Finally, Cantor Fitzgerald reiterated a “buy” rating and issued a $245.00 price objective on shares of Cigna in a research note on Sunday, April 21st. One research analyst has rated the stock with a sell rating, three have given a hold rating and fourteen have given a buy rating to the company’s stock. Cigna presently has an average rating of “Buy” and an average target price of $214.55.
Cigna Company Profile
Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.
Further Reading: What is the CBOE Russell 2000® Volatility Index?
Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.